The single largest modifiable predictor of all-cause mortality — in women just as in men.
—
—
Good news up front: thyroid, liver, kidneys, iron, B12, folate, and reproductive hormones are all solid. Two flags worth acting on, and a few tests worth adding to your next panel.
Read it together: you're not diabetic — your long-term glucose control (A1c 5.7%) is still fine and the 2-hour OGTT clears normally. But fasting glucose over 100 plus HOMA-IR 3.5 plus a brisk 60-min glucose rise is the early signal of insulin resistance creeping in. This is the most exercise-responsive marker on your whole panel. Walking 10–15 min after meals, Zone 2 cardio 3×/week, and strength training (muscle is the body's biggest glucose-disposal organ) all move this number fast. Catching it at 42 is the whole value of a baseline.
HDL at 54 sits in the "moderate" zone by lab cutoff, but your TG:HDL ratio is 1.22 — a much more useful number, and it's excellent. That ratio strongly predicts absence of atherogenic dyslipidemia. Exercise and omega-3 will nudge HDL upward over time. The important lipid number you're missing is apoB — worth adding to next year's panel.
Low enough that correction is worth doing. Spain sun exposure helps once you're there, but not enough on its own. 2,000–4,000 IU/day with vitamin K2 (100 mcg) and a meal with fat. Retest in 3 months, aim to land between 40–50 ng/mL.
Clear premenopausal pattern — FSH is low, LH is normal, estradiol is strong. The day of the draw caught you in a late-follicular / ovulatory window (high estradiol, low FSH). No perimenopause markers yet. Worth re-checking annually after 45 to track the trajectory.
Uric acid 6.6 is slightly above the female reference range — not urgent, usually hydration- or diet-related (purines, fructose, alcohol). Watch on next panel. Everything else in this group is clean.
The InBody scan is the piece that explains the metabolic signal. Muscle mass is fine; body fat is what's elevated — and the visceral fat component (fat stored around organs) is what links directly to the insulin-resistance pattern in your blood work. Good news: one intervention stack fixes both.
Why this matters: the visceral fat at 95.8 cm² and body-fat % at 33.3 are almost certainly what's driving the fasting glucose 108 + HOMA-IR 3.5 + HDL 54 pattern in your blood panel. These aren't independent findings — they're one story. Drop 6–8 kg of fat (target ~60 kg at retained muscle) and the metabolic numbers typically follow. Your muscle mass is solid, which is a big advantage for the recomp — you're protecting, not rebuilding.
Limb muscle is balanced left-to-right (within 2%) and legs are actually above expected (104% / 102%) — no obvious imbalances to correct. A strength program focused on compound lifts + protein intake will preserve this through a fat-loss phase.
The numbers that flagged in February were fasting glucose 108, HOMA-IR 3.5, HDL 54, body fat 33.3%, visceral fat 95.8 cm². All of those are expected to have moved meaningfully with 9 kg of fat loss — but right now it's an assumption. A new InBody + a targeted blood panel tells you the truth.
New InBody: book with the nutritionist — 15-minute scan shows if body fat %, fat mass, visceral fat, and most importantly muscle mass moved the right way. Repeat blood panel: fasting glucose, HbA1c, fasting insulin, HOMA-IR, full lipid panel, vitamin D recheck. If you're adding anything, this is the visit to also get apoB, Lp(a), hs-CRP. ~€120–200 at Quirónsalud.
You're essentially at the InBody target weight. The risk now isn't gaining fat back — it's losing muscle. At 1.3 kg/week of weight loss, some lean-mass loss is likely, which drops basal metabolic rate and makes maintenance harder. The fix is straightforward: hit protein daily and train strength 2–3×/week.
Protein target: ~110–115 g/day (1.9 g per kg of your current weight) — this is the single most important thing for preserving muscle at maintenance. Strength training: 2–3× per week with progressive load (Pilates reformer, dumbbells, bodyweight). Even 30-minute sessions work.
These three cover muscle retention, cardiovascular/cognitive support, and correcting your one deficiency. Especially valuable in a maintenance phase after weight loss.
Creatine monohydrate 5 g/day — particularly important now for muscle retention and cognition. Omega-3 2–3 g EPA+DHA/day with food (third-party tested, IFOS 5-star). Vitamin D 2,000–4,000 IU + K2 100 mcg daily until retest shows 40–50 ng/mL.
Weight and body comp are in a good place. The next-highest-leverage healthspan marker is cardio fitness. You don't need to overhaul anything — a few extra "slightly harder" sessions per week gradually raise VO₂max, which is the #1 all-cause-mortality predictor for women in their 40s.
Shape: 3 easy-pace walks or bike rides per week (45–60 min, conversational = Zone 2) + 1 slightly harder session (brisk hike with hills, stairs, a short interval bike workout). Track VO₂max estimate from Apple Watch / Garmin if you wear one.
Still worth doing. Rapid weight loss can affect bone density, so getting a scan now (post-loss) gives you a cleaner reference point than scanning during the cutting phase. Bone density becomes increasingly important approaching perimenopause.
Cost: ~€60–100 in Málaga. Repeat every 2–3 years. Gives you body fat %, lean mass, visceral fat, and bone density (T-score) in one 10-minute scan.
Interventions with the largest effects on healthspan and mortality. These are the foundation before anything else matters.
The single strongest predictor of how long and how well you live. Built through easy-pace cardio (Zone 2) + occasional harder efforts.
Target — p90 for women 40–49
Muscle is the organ of longevity for women. Preserving it through your 40s and 50s protects metabolism, bone density, fall risk, and independence in the final decades.
Target — p90 for women 40s
Most underrated healthspan intervention. Sleep quality and consistency both matter — 8 hours in a chaotic window isn't the same as 8 hours at a stable bedtime.
Target
Visceral fat (the fat around organs) is what actually drives cardiovascular risk — not bodyweight or appearance. DEXA is the gold standard for knowing what's real vs. what's noise.
Target — healthy range
Iron deficiency is shockingly common in women — especially if still menstruating, training, or eating less red meat. Low ferritin silently tanks energy, mood, exercise capacity, and cognitive function. Test, don't guess.
Target
Women lose 1–2% of bone density per year around menopause. Starting strong and maintaining matters enormously — osteoporosis is the leading cause of loss-of-independence in older women, and prevention is far more effective than treatment.
Target
Knowing your baseline while everything is working well gives you a reference point for later. Perimenopause can start in the early 40s and is easier to manage when you know your starting place. Modern HRT evidence has shifted substantially in the last 5 years — worth being informed before symptoms arrive.
Target — baseline data
Women metabolize alcohol differently than men and show cardiovascular + cognitive effects at lower doses. The optimal amount may be lower than cultural "moderate" framing suggests.
Target
The next unit of effort once Tier 1 is in place.
Essential for preserving lean mass through your 40s and beyond. Older muscle is harder to build and easier to lose — hitting the protein target is the defense.
Target
Evidence in women is particularly strong for cognition and bone density, not just muscle. One of the cheapest, safest, best-studied supplements in existence.
Target
Cardiovascular, cognitive, and possibly hormonal benefits. Quality matters — oxidized fish oil is net negative, so brand choice is not trivial.
Target
Work as a team — vitamin D regulates absorption, calcium is the building block, K2 directs calcium to bones instead of arteries. Spain's sun helps, but worth confirming with a blood test.
Target
Cardiovascular disease is the leading cause of death in women — and women's CVD is often diagnosed later because it presents differently. ApoB is the best single lipid number; knowing yours in your 40s gives you decades to steer the trajectory.
Target